Breast cancer is the most common disease in the European Union, accounting for 13.3 per cent of all new cancer cases in 2020. Breast cancer is expected to affect 1 in every 11 women in the EU by the age of 74.
Women with breast cancer will be enrolled in a clinical trial to investigate the ability of behavioural and psychological therapy to minimise the cardiac damage caused by anti-cancer medications. The unique CARDIOCARE initiative is being led by a coalition of European partners, including the
Washington [US], May 24 (ANI): The findings of a new research suggests that certain anti-cancer therapies may hasten cellular aging, where changes in the DNA of patients may contribute to greater inflammation and fatigue.